Literature DB >> 8201476

Diagnostic value of anti-neutrophil cytoplasmic and anti-endothelial cell antibodies in early Kawasaki disease.

J Guzman1, M Fung, R E Petty.   

Abstract

OBJECTIVE: To assess the diagnostic potential of anti-neutrophil cytoplasmic antibodies (ANCA) and anti-endothelial cell antibodies (AECA) to distinguish early Kawasaki disease (KD) from febrile diseases resembling KD.
DESIGN: Case-control study.
SETTING: Tertiary care facility. PATIENTS: Eighteen patients with KD tested within 2 weeks of disease onset and before immune globulin therapy; 20 control children with fever and at least one other KD criterion; 21 children with noninflammatory disorders (patients scheduled for elective surgery, or after trauma).
METHODS: We detected ANCA by immunofluorescence and enzyme-linked immunosorbent assay (ELISA), and AECA by a cell-ELISA with fixed human umbilical vein endothelial cells.
RESULTS: We found that 7 of 18 patients with KD and 6 of 20 febrile control patients had ANCA (by immunofluorescence or ELISA, p value not significant); 3 of 18 patients with KD and 8 of 20 febrile control patients had AECA (p value not significant). One of three patients with KD who had aneurysms had ANCA; none had AECA.
CONCLUSIONS: The ANCA and AECA tests used in this study did not differentiate early KD from other childhood diseases with which it may be confused.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8201476     DOI: 10.1016/s0022-3476(05)83180-4

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  9 in total

1.  Study of the autoantibody profile after the acute phase of Kawasaki disease in a cohort of children from North India.

Authors:  R Venkatraman; S Singh; R W Minz
Journal:  Rheumatol Int       Date:  2005-11-25       Impact factor: 2.631

Review 2.  Antineutrophil cytoplasm antibodies and vasculitis.

Authors:  M C Nash; M J Dillon
Journal:  Arch Dis Child       Date:  1997-09       Impact factor: 3.791

3.  Noninvasive determination of endothelial cell function in the microcirculation in Kawasaki syndrome.

Authors:  Gregory H Kurio; Katrine A Zhiroff; Lily J Jih; Arnost S Fronek; Jane C Burns
Journal:  Pediatr Cardiol       Date:  2007-09-21       Impact factor: 1.655

4.  The role of anti-endothelial cell antibodies in Kawasaki disease - in vitro and in vivo studies.

Authors:  E Grunebaum; M Blank; S Cohen; A Afek; J Kopolovic; P L Meroni; P Youinou; Y Shoenfeld
Journal:  Clin Exp Immunol       Date:  2002-11       Impact factor: 4.330

5.  Anti-endothelial cell antibodies are prevalent in juvenile idiopathic arthritis: implications for clinical disease course and pathogenesis.

Authors:  Bradley J Bloom; Mieko Toyoda; Anna Petrosian; Stanley Jordan
Journal:  Rheumatol Int       Date:  2006-12-13       Impact factor: 3.580

Review 6.  Clinical aspects of primary vasculitis.

Authors:  C A Stegeman; C G Kallenberg
Journal:  Springer Semin Immunopathol       Date:  2001

Review 7.  How Should We Classify Kawasaki Disease?

Authors:  Edoardo Marrani; Jane C Burns; Rolando Cimaz
Journal:  Front Immunol       Date:  2018-12-14       Impact factor: 7.561

Review 8.  Pathogenic mechanisms of anti-endothelial cell antibodies (AECA): their prevalence and clinical relevance.

Authors:  Cristiano Alessandri; Michele Bombardieri; Guido Valesini
Journal:  Adv Clin Chem       Date:  2006       Impact factor: 5.394

Review 9.  Current Insights Into the Pathophysiology of Multisystem Inflammatory Syndrome in Children.

Authors:  Laura A Vella; Anne H Rowley
Journal:  Curr Pediatr Rep       Date:  2021-10-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.